All stock lists
ClearBridge Energy Midstream Opportunity Fund Inc. (New York Stock Exchange:EMO)
US · Delayed Price · Currency is USD
Financial Services · Asset Management
52.26+0.54 (+1.04%)
Market cap
$1.05B
Health Score
Analyst consensus
Listed since
Jun 14, 2011
Insider Score
––Not scored
EMO Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
Financial Health Score
Fair
From EMO’s reported statements · Q2 2026 (trailing 12 months)
Profitability20 / 20
Keeps a healthy share of every dollar it sells.
- Revenue
- $99.3M
- Net income
- $353.8M
- Net margin
- 356.1%
Leverage17 / 20
Little or no net debt.
- Total debt
- $265.9M
- Cash
- $40
- Net debt / EBITDA
- 0.57x
Liquidity0 / 20
Owes more within a year than it holds to pay it.
- Current assets
- $52.2M
- Current liabilities
- $184.0M
- Current ratio
- 0.28
Cash generation20 / 20
The business funds itself from operations.
- Operating cash flow
- $57.5M
- Free cash flow
- $57.5M
- FCF margin
- 57.9%
Dilution & runway0 / 20
Heavy dilution — shareholders are paying for the business.
- Shares outstanding
- 20.0M
- Share growth (1y)
- 56.5%
Five pillars — profitability, leverage, liquidity, cash generation, dilution & runway — each scored 0–20 from the company’s own income statement, balance sheet and cash-flow statement, then scaled to 100. A pillar the statements cannot answer is left out rather than guessed; fewer than three and no score is shown.
EMO Income Statement
| Fiscal Period | Q2 2026 | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 | Q4 2023 |
|---|---|---|---|---|---|---|
| Period Ending | May 31, 2026 | Nov 30, 2025 | May 31, 2025 | Nov 30, 2024 | May 31, 2024 | Nov 30, 2023 |
| Revenue | 17.43 M | 28.81 M | 25.18 M | 27.93 M | 112.07 M | 100.69 M |
| Revenue Growth (YoY) | -84.45 % | -71.39 % | 90.33 % | -3.57 % | 238.49 % | 119.36 % |
| Cost of Revenue | 9.36 M | 11.36 M | 5.94 M | 3.83 M | 3.22 M | 3.42 M |
| Gross Profit | 8.06 M | 17.45 M | 19.23 M | 24.10 M | 108.85 M | 97.26 M |
| SG&A Expense | 0.00 | 0.00 | 0.00 | -242.22 M | -10.97 M | 0.00 |
| R&D Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | -230.83 M | -25.71 M | 98.32 M | -242.22 M | -10.97 M | -13.52 M |
| Operating Income | 238.89 M | 43.16 M | -79.09 M | 266.32 M | 97.89 M | 110.79 M |
| Pretax Income | 234.47 M | 41.95 M | -87.74 M | 260.10 M | 92.02 M | 104.34 M |
| Tax Provision | 51.18 M | 3.73 M | -14.04 M | 54.15 M | 2.71 M | -24.99 K |
| Net Income | 183.30 M | 38.21 M | -73.70 M | 205.96 M | 89.31 M | 104.36 M |
| EPS (Basic) | 9.16 | 1.91 | -4.05 | 13.09 | 6.98 | 8.16 |
| EPS (Diluted) | 9.16 | 1.91 | -4.05 | 13.09 | 6.98 | 8.16 |
| Shares Outstanding | 20.01 M | 20.01 M | 18.19 M | 15.73 M | 12.79 M | 12.79 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.